Le Lézard
Classified in: Health, Business
Subjects: PET, CXP

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment


YEMASSEE, S.C., Dec. 12, 2018 /PRNewswire/ -- Primate contract research organization Alpha Genesis today announced the second phase of its multi-year expansion effort, committing an additional $3M over the next two years towards new construction and hiring to further enhance the Company's product and service offerings. This announcement follows a prior $2M initiative announced in 2016 which resulted in the Company building 50,000 square feet of new research space, and creating 30 full-time technical positions. The overall goal of these efforts is to position Alpha Genesis to effectively compete with Chinese expansion efforts in the primate bio-research industry. 

After experiencing several years of rapid growth, Alpha Genesis, which specializes in providing primate research products and services, plans to build a new and larger quarantine holding facility, and to enhance its service offerings by purchasing more specialized medical research equipment and hiring additional research staff. The Company will continue its outreach efforts to the European pharmaceutical community which continues to outsource much of its research needs to foreign entities, most notably to companies based in China and to a lesser extent to companies based in the United States. Alpha Genesis seeks to keep pace with Chinese research development efforts to provide a viable North American pre-clinical alternative. 

The Alpha Genesis Primate Research Center maintains a colony of 6,000 monkeys in South Carolina. Already, over 35% of its business focuses on in-house primate research, often for European companies, in the area of vaccine development and drug evaluation. Unlike most US-based primate CROs, Alpha Genesis raises most of its research animals domestically in order provide the highest standards of quality control, as well as to ensure a steady supply of research primates on known genetic origin. "My understanding is that restrictions in Europe have become quite significant in terms of how animals, particularly primates, must be housed and maintained, which has significantly driven up costs. The Chinese have seized on this opportunity by developing their own research resources and supply chain, and we are seeking to directly compete, but at a higher level, therein lies the reasoning and motivation for continued expansion of our facilities and staff expertise." says Westergaard. 

About AGI

Alpha Genesis is a leading life sciences company that provides primates and primate research services worldwide. With a mission to improve health and improve lives, Alpha Genesis delivers world-class solutions to the primate research community. To learn more about Alpha Genesis, visit www.alphagenesisinc.com and to learn more about the AGI Primate Research Center, visit www.primateresearch.com.

Media Inquiries: [email protected]

 

SOURCE Alpha Genesis


These press releases may also interest you

at 10:44
Ivy Rehab, a premier provider of outpatient musculoskeletal rehabilitative services and pediatric therapy nationwide, is pleased to announce its partnership with Hilltop Physical Therapy, further solidifying its reach in Virginia....

at 10:37
Many people are searching for ways to boost brain health as they age and deal with cognitive decline. Sun Chlorella has answered the call with its...

at 10:35
Aubex Therapeutics Inc., a pioneering biotechnology firm, today announced its official launch, heralding a new era in the battle against cancer. Under the guidance of Board Member and Interim CEO, Jeffrey Glazer, Aubex's initial program is focused on...

at 10:33
Front Line Medical Technologies Inc, a leader in innovative medical devices for emergency and trauma care, today announced that its innovative COBRA-OS® (Control Of Bleeding, Resuscitation, Arterial Occlusion System) has officially been granted CE...

at 10:32
Onyx Behavioral Health, a leading primary mental health residential treatment facility, alongside its parent company USR Holdings LLC, is excited to announce its participation in the 2024 Safety Festival at Clover Park in Port Saint Lucie on...

at 10:30
ZERO Prostate Cancer, the nation's leading prostate cancer organization, is pleased to announce the appointment of Brian Bragg as its first-ever Chief Mission Officer. Bragg, a distinguished expert in the healthcare and community health space, will...



News published on and distributed by: